Hoping to encourage sufficient investments by pharmaceutical companies in expensive gene therapies, which often consist of a single treatment, experts outline an alternative payment model.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/b...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/b...